These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18425817)

  • 21. Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.
    Hawinkels LJ; Verspaget HW; van der Reijden JJ; van der Zon JM; Verheijen JH; Hommes DW; Lamers CB; Sier CF
    Cancer Sci; 2009 Apr; 100(4):663-70. PubMed ID: 19462508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats.
    Sun H; Zhao Y; Bi X; Li S; Su G; Miao Y; Ma X; Zhang Y; Zhang W; Zhong M
    Diagn Pathol; 2015 Apr; 10():18. PubMed ID: 25884585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.
    Wang S; Shiva S; Poczatek MH; Darley-Usmar V; Murphy-Ullrich JE
    J Biol Chem; 2002 Mar; 277(12):9880-8. PubMed ID: 11784717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
    Papageorgis P; Lambert AW; Ozturk S; Gao F; Pan H; Manne U; Alekseyev YO; Thiagalingam A; Abdolmaleky HM; Lenburg M; Thiagalingam S
    Cancer Res; 2010 Feb; 70(3):968-78. PubMed ID: 20086175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-beta activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2.
    Wang S; Skorczewski J; Feng X; Mei L; Murphy-Ullrich JE
    J Biol Chem; 2004 Aug; 279(33):34311-22. PubMed ID: 15184388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.
    Venkatraman L; Chia SM; Narmada BC; White JK; Bhowmick SS; Forbes Dewey C; So PT; Tucker-Kellogg L; Yu H
    Biophys J; 2012 Sep; 103(5):1060-8. PubMed ID: 23009856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.
    Brown AR; Simmen RC; Raj VR; Van TT; MacLeod SL; Simmen FA
    Carcinogenesis; 2015 Sep; 36(9):946-55. PubMed ID: 26210742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
    Toyooka S; Toyooka KO; Harada K; Miyajima K; Makarla P; Sathyanarayana UG; Yin J; Sato F; Shivapurkar N; Meltzer SJ; Gazdar AF
    Cancer Res; 2002 Jun; 62(12):3382-6. PubMed ID: 12067979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential roles of EPS8 in carcinogenesis: loss of protein expression in a subset of colorectal carcinoma and adenoma.
    Abdel-Rahman WM; Ruosaari S; Knuutila S; Peltomäki P
    World J Gastroenterol; 2012 Aug; 18(29):3896-903. PubMed ID: 22876043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular interactions that confer latency to transforming growth factor-beta.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Sep; 279(36):38032-9. PubMed ID: 15208302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
    Cardillo MR; Yap E
    J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical role of thrombospondin-1 in promoting intestinal mucosal wound repair.
    Wilson ZS; Raya-Sandino A; Miranda J; Fan S; Brazil JC; Quiros M; Garcia-Hernandez V; Liu Q; Kim CH; Hankenson KD; Nusrat A; Parkos CA
    JCI Insight; 2024 Jul; 9(17):. PubMed ID: 39078701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
    Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
    J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.